Connection
Daniel Bowles to Pyrroles
This is a "connection" page, showing publications Daniel Bowles has written about Pyrroles.
|
|
Connection Strength |
|
|
|
|
|
0.452 |
|
|
|
-
Goldman J, Eckhardt SG, Borad MJ, Curtis KK, Hidalgo M, Calvo E, Ryan DP, Wirth LJ, Parikh A, Partyka J, Faessel H, Gangolli E, Stewart S, Rosen LS, Bowles DW. Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumors. Clin Cancer Res. 2015 Mar 01; 21(5):1002-9.
Score: 0.452